Concentration of cord serum placenta growth factor in normal and diabetic pregnancies

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 1, 2005, Pages 75-79

  Loukovaara, Mikko ^a   Leinonen, Pekka ^a   Teramo, Kari ^a   Andersson, Sture ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; INSULIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN;

ADULT; AMNION FLUID; ANGIOGENESIS; ARTERIAL GAS; ARTICLE; BLOOD GAS; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORD SERUM; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS HYPOXIA; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MACROSOMIA; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; PH ELECTRODE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; UMBILICAL ARTERY;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY PROTEINS; REGRESSION ANALYSIS;

EID: 11844285680     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00337.x     Document Type: Article

References (23)

1. Hauser S, Weich HA. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 1993;9:259-268.
2. Maglione D, Guerriero V, Viglietto G, et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 1993;8: 925-931.
3. Cao Y, Chen H, Zhou L, et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem 1996;271:3154-3162.
4. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991;88:9267-9271.
5. Olofsson B, Pajusola K, Kaipainen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996;93:2576-2581.
6. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999;237:1-30.
7. Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001;7:575-583.
8. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
9. Tony DS, Wang H-S, Wang T-H, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998;179:1539-1544.
10. Reuvekamp A, Velsing-Aarts FV, Poulina IEJ, Capello JJ, Duits AJ. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1999;106: 1019-1022.
11. Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, Sibai BM. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 2000;183:1554-1557.
12. Maynard SE, Min J-Y, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-658.
13. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188:177-182.
14. Khaliq A, Dunk C, Jiang J, et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for 'placental hyperoxia' in intrauterine growth restriction. Lab Invest 1999;79: 151-170.
15. Gleadle JM, Ebert BL, Firth JD, Ratcliffe PJ. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 1995;268:C1362-C1368.
16. Schwartz R, Teramo KA. Effect of diabetic pregnancy on the fetus and newborn. Semin Perinatol 2000;24:120-135.
17. Hyvönen K. Gestaatiodiabeteksen esiintyvyys ja seulonta [Incidence and screening of gestational diabetes]. Finland: Publications of the University of Kuopio, Original reports 6/1991. Kuopio, 1991.
18. Teramo KA, Widness JA, demons GK, Voutilainen PE, McKinlay S, Schwartz R. Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol 1987;69:710-716.
19. Husari M, Markkanen H, Puttonen H, Teramo K. Lapsiveden erytropoietiinipitoisuus normaaleissa ja patologisissa raskauksissa [Amniotic fluid erythropoietin levels in normal and pathological pregnancies]. Duodecim 1998;114:2315-2321.
20. Pihkala J, Hakala T, Voutilainen P, Raivio K. Uudet suomalaiset sikiön kasvukäyrät [Characteristic of recent fetal growth curves in Finland]. Duodecim 1989;105:1540-1546.
21. Lassus P, Teramo K, Nupponen I, Markkanen H, Cederqvist K, Andersson S. Vascular endothelial growth factor and angiogenin levels during fetal development and in maternal diabetes. Biol Neonate 2003;84:287-292.
22. Seubert DE, Maymon E, Pacora P, et al. A study of the relationship between placenta growth factor and gestational age, parturition, rupture of membranes, and intrauterine infection. Am J Obstet Gynecol 2000;182:1633-1637.
23. Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997;18:801-831.